CVS Health's Q2 Earnings Preview

CVS Health CVS announces its next round of earnings this Wednesday, August 7. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement.

Earnings and Revenue

Wall Street analysts see CVS Health reporting earnings of $1.69 per share on sales of $62.65 billion.

CVS Health reported a profit of $1.69 when it published results during the same quarter last year. Sales in that period totaled $46.71 billion. Revenue would be up 34.13% from the same quarter last year. Here's how the company's EPS has stacked up against analyst estimates in the past:

 

Quarter Q1 2019 Q4 2018 Q3 2018 Q2 2018
EPS Estimate 1.500 2.05 1.71 1.61
EPS Actual 1.620 2.14 1.73 1.69

Stock Performance

Over the last 52-week period, shares are down 16%. Given that these returns are generally negative, long-term shareholders are probably upset going into this earnings release. Over the past 90 days, analysts have generally not modified their estimates for EPS and revenues. The popular rating by analysts on CVS Health stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.

Conference Call

CVS Health is scheduled to hold a conference call at 8:00 a.m. ET and it can be accessed here: https://event.on24.com/wcc/r/2017308/CD2A373DDD696235246935AF1A6D9918

CVS Logo
CVSCVS Health Corp
$67.611.87%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
86.36
Growth
57.38
Quality
25.96
Value
42.42
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...